<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Venous thrombosis and thromboembolism (VTE) in children: Risk factors, clinical manifestations, and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Venous thrombosis and thromboembolism (VTE) in children: Risk factors, clinical manifestations, and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Venous thrombosis and thromboembolism (VTE) in children: Risk factors, clinical manifestations, and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Manuela Albisetti, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Anthony KC Chan, MBBS, FRCPC, FRCPath
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sarah O'Brien, MD, MSc
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carrie Armsby, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 22, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The incidence of venous thromboembolism (VTE; which includes venous thrombosis and/or pulmonary embolism [PE]) during childhood is considerably lower than that seen in adults; however, VTE is increasingly recognized in the pediatric population as a complication of contemporary health care.
        </p>
        <p>
         This review summarizes the available information on the incidence, risk factors, clinical manifestations, and diagnosis of VTE in children beyond the neonatal period, excluding VTE in the central nervous system. Other aspects of VTE are discussed in separate topic reviews:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Treatment, prevention, and outcome of noncerebral VTE in children (see
         <a class="medical medical_review" href="/z/d/html/5916.html" rel="external">
          "Venous thrombosis and thromboembolism (VTE) in children: Treatment, prevention, and outcome"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         VTE in the newborn (see
         <a class="medical medical_review" href="/z/d/html/5912.html" rel="external">
          "Neonatal thrombosis: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5911.html" rel="external">
          "Neonatal thrombosis: Management and outcome"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         VTE in children with cancer (see
         <a class="medical medical_review" href="/z/d/html/6236.html" rel="external">
          "Thromboembolism in children with cancer"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cerebral venous thrombosis (see
         <a class="medical medical_review" href="/z/d/html/1103.html" rel="external">
          "Cerebral venous thrombosis: Etiology, clinical features, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1109.html" rel="external">
          "Cerebral venous thrombosis: Treatment and prognosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          INCIDENCE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Estimates of the incidence of VTE in the general pediatric population range from 0.14 to 0.21 per 10,000 children per year [
         <a href="#rid1">
          1,2
         </a>
         ]. Among hospitalized pediatric patients, the incidence of VTE is approximately 0.2 to 1 percent [
         <a href="#rid3">
          3-6
         </a>
         ]. Pulmonary embolism (PE) accounts for approximately 15 percent of VTE episodes [
         <a href="#rid7">
          7
         </a>
         ]. Rates of VTE and PE are highest among children with underlying medical conditions, such as malignancy and cardiac disease [
         <a href="#rid3">
          3-5
         </a>
         ]. One study reported a fivefold higher incidence of VTE among children admitted to tertiary children's hospitals compared with community hospitals, which likely reflects the greater risk associated with more complex care [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
         In a prospective registry study in the Netherlands, the majority of VTE episodes (85 percent) occurred in the hospital setting and nearly all patients (98 percent) had at least one underlying risk factor [
         <a href="#rid1">
          1
         </a>
         ]. In this study, one-third of the cases were associated with a central venous catheter (CVC).
        </p>
        <p>
         In two studies using data from the Pediatric Health Information System administrative database (2001 to 2007 and 2008 to 2019), the annual rate of VTE among hospitalized children has risen from 0.3 percent in 2001 to 1.1 percent in 20019 [
         <a href="#rid3">
          3,6
         </a>
         ]. These studies were unable to determine whether this increase represented a true increase in the frequency of VTE or improved detection of VTE.
        </p>
        <p>
         In a national registry study from Denmark, rates of pediatric VTE were highest among infants and adolescents [
         <a href="#rid2">
          2
         </a>
         ]. Most affected patients (87 percent) had at least one underlying condition or trigger for VTE; one-third were found to have underlying thrombophilia (eg, factor V Leiden mutation, antithrombin deficiency, protein C or S deficiency, antiphospholipid antibodies). Use of estrogen-containing contraceptives was an important risk factor for VTE among adolescent girls (80 percent of girls with VTE used contraceptives, as compared with 27 percent in the general population).
        </p>
        <p class="headingAnchor" id="H3832532903">
         <span class="h1">
          RISK OF VTE IN CHILDREN VERSUS ADULTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risk of VTE is substantially lower in children compared with adults. Several factors may protect children from VTE, contributing to the relatively low incidence of VTE throughout childhood:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Children less commonly develop diseases causing damage to the vascular endothelium (eg, diabetes, dyslipidemias, hypertension).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Children are less frequently exposed to acquired prothrombotic risk factors (eg, oral contraceptives, hormone replacement therapy, pregnancy and puerperium, smoking, malignancy, orthopedic surgery).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         As compared with adults, children have lower plasma concentrations of all vitamin K-dependent factors and almost all contact factors, as well as reduced capacity to generate thrombin [
         <a href="#rid8">
          8,9
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The capacity to inhibit thrombin is enhanced throughout childhood due to increased plasma concentrations of the thrombin inhibitor alpha-2-macroglobulin [
         <a href="#rid8">
          8-10
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Risk factors and the epidemiology of VTE in adults are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1361.html" rel="external">
          "Overview of the causes of venous thrombosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          RISK FACTORS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Risk factors for VTE are summarized by Virchow's triad: endothelial injury, stasis, and hypercoagulability [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
         In children, the most common risk factor for VTE is the presence of a central venous catheter (CVC). Other risk factors include inherited hypercoagulable state, infection, trauma, immobility, malignancy, and chronic inflammatory conditions  (
         <a class="graphic graphic_table graphicRef122844" href="/z/d/graphic/122844.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Central venous access devices
         </span>
         <span class="headingEndMark">
          —
         </span>
         Approximately one- to two-thirds of VTEs in children are associated with CVCs [
         <a href="#rid1">
          1,5,12
         </a>
         ]. CVCs are often necessary in the short- and long-term medical management of pediatric patients (eg, for administration of parenteral nutrition, chemotherapy, intensive fluid therapy, vasoactive infusions, or prolonged antibiotic therapy).
        </p>
        <p>
         Indwelling CVCs are thrombogenic because they present a foreign intravascular surface, damage vessel walls, and disrupt blood flow. (See
         <a class="medical medical_review" href="/z/d/html/8180.html" rel="external">
          "Central venous catheters: Overview of complications and prevention in adults"
         </a>
         .)
        </p>
        <p>
         Several factors may influence the risk of CVC-associated VTE, including [
         <a href="#rid13">
          13-20
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Type of catheter
         </strong>
         – In most studies, peripherally inserted central catheters (PICCs) appear to carry a higher risk of VTE compared with other types of CVCs, with rates ranging from 1 to 9 percent for PICCs versus 0.5 to 3 percent for other CVCs [
         <a href="#rid13">
          13-16,21
         </a>
         ]. However, some studies reported comparable or lower rates of VTE for PICCs compared with other catheter types [
         <a href="#rid17">
          17,18
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Location of the catheter
         </strong>
         – VTEs can occur in the upper venous system (in association with CVCs inserted through the jugular or subclavian vein) or in the lower extremities (in association with CVCs placed in the femoral vein) [
         <a href="#rid19">
          19,20
         </a>
         ]. In some studies, the risk of VTE appears to be higher with upper extremity CVCs compared with lower extremity [
         <a href="#rid13">
          13,19
         </a>
         ]; while other studies found similar rates of VTE regardless of location [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Size of catheter
         </strong>
         – The risk of VTE is increased when the diameter of the catheter is large relative to the size of the vessel.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Number of lumens
         </strong>
         – The risk of VTE appears to be increased with multi-lumen compared with single-lumen catheters.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Concomitant thrombophilic conditions
         </strong>
         – Patients with underlying thrombophilic conditions (eg, cancer, trauma, infection) are at higher risk of developing CVC-associated VTE. (See
         <a class="local">
          'Other risk factors'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Inherited thrombophilia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Studies in adults have demonstrated a strong association between inherited thrombophilia and VTE. However, the impact of these disorders on the development of VTE during childhood remains poorly defined and controversial [
         <a href="#rid22">
          22-26
         </a>
         ]. As discussed above, several factors may protect individuals with IT from developing VTE during childhood. (See
         <a class="local">
          'Risk of VTE in children versus adults'
         </a>
         above.)
        </p>
        <p>
         The ITs for which the pathogenic link is most clearly established include  (
         <a class="graphic graphic_table graphicRef88804" href="/z/d/graphic/88804.html" rel="external">
          table 2
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Factor V Leiden mutation (see
         <a class="medical medical_review" href="/z/d/html/1355.html" rel="external">
          "Factor V Leiden and activated protein C resistance"
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prothrombin G20210A mutation (see
         <a class="medical medical_review" href="/z/d/html/1359.html" rel="external">
          "Prothrombin G20210A"
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Antithrombin deficiency (see
         <a class="medical medical_review" href="/z/d/html/1360.html" rel="external">
          "Antithrombin deficiency"
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Protein C deficiency (see
         <a class="medical medical_review" href="/z/d/html/1354.html" rel="external">
          "Protein C deficiency"
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Protein S deficiency (see
         <a class="medical medical_review" href="/z/d/html/1357.html" rel="external">
          "Protein S deficiency"
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         In children with VTE, the reported prevalence of IT varies greatly, ranging from approximately 10 to 60 percent, depending on the population studied and the tests used [
         <a href="#rid2">
          2,27-35
         </a>
         ]. The prevalence is highest in children with unprovoked VTE and lowest in patients with CVC-associated VTE [
         <a href="#rid34">
          34
         </a>
         ].
        </p>
        <p>
         The approach to testing for IT in children with VTE is summarized in the algorithm  (
         <a class="graphic graphic_algorithm graphicRef91835" href="/z/d/graphic/91835.html" rel="external">
          algorithm 1
         </a>
         ) and discussed in a separate topic review. (See
         <a class="medical medical_review" href="/z/d/html/5920.html" rel="external">
          "Thrombophilia testing in children and adolescents", section on 'Children with venous thromboembolism'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Other risk factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other risk factors that are frequently associated with VTE in children include  (
         <a class="graphic graphic_table graphicRef122844" href="/z/d/graphic/122844.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid36">
          36,37
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Age
         </strong>
         – The incidence of pediatric VTE according to age shows two peaks, one in infancy and the second in adolescence. The first peak reflects the increased risk of VTE in preterm infants, largely due to the presence of invasive catheters. (See
         <a class="medical medical_review" href="/z/d/html/5912.html" rel="external">
          "Neonatal thrombosis: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Infection
         </strong>
         – Children with severe systemic bacterial infections are at increased risk of developing VTE. This can occur with any pathogen, but it is particularly well described in meningococcal infections. (See
         <a class="medical medical_review" href="/z/d/html/6395.html" rel="external">
          "Sepsis in children: Definitions, epidemiology, clinical manifestations, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1300.html" rel="external">
          "Clinical manifestations of meningococcal infection"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         VTE can also occur as a complication of systemic viral infections. This is particularly well described for coronavirus disease 2019 (COVID-19) [
         <a href="#rid38">
          38
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/127926.html" rel="external">
          "COVID-19: Hypercoagulability"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/128389.html" rel="external">
          "COVID-19: Management in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Malignancy
         </strong>
         – VTE can occur as a complication of any pediatric malignancy. VTE is particularly common in children with acute lymphoblastic leukemia who are treated with asparaginase. This is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6236.html" rel="external">
          "Thromboembolism in children with cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6245.html" rel="external">
          "Treatment of acute lymphoblastic leukemia/lymphoma in children and adolescents", section on 'Induction chemotherapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Congenital heart disease
         </strong>
         – The risk is VTE is particularly high in patients with single-ventricle physiology and those who have undergone surgical repair involving placement of a conduit or prosthetic valve. (See
         <a class="medical medical_review" href="/z/d/html/95232.html" rel="external">
          "Management of complications in patients with Fontan circulation", section on 'Thrombosis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8171.html" rel="external">
          "Antithrombotic therapy for mechanical heart valves"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Trauma
         </strong>
         – The risk of VTE increases following major traumatic injury; however, the risk in children is substantially lower compared with adult trauma patients. In reports from large trauma registries and administrative databases, the rates of VTE in pediatric trauma patients were quite low (0.03 to 0.4 percent); however, these studies may underestimate the true incidence [
         <a href="#rid39">
          39,40
         </a>
         ]. In one study of 1934 pediatric patients managed at a level I trauma center, VTE occurred in 1.2 percent [
         <a href="#rid41">
          41
         </a>
         ]. The risk was highest among patients with a major vascular injury (14 percent) and those requiring orthopedic surgery (5 percent). (See
         <a class="medical medical_review" href="/z/d/html/113028.html" rel="external">
          "Venous thromboembolism risk and prevention in the severely injured trauma patient", section on 'Risk factors'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Estrogen-containing contraceptives
         </strong>
         – The risk of VTE associated with estrogen-containing contraceptives is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7399.html" rel="external">
          "Combined estrogen-progestin contraception: Side effects and health concerns", section on 'Venous thromboembolism'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nephrotic syndrome
         </strong>
         – The risk of thrombosis in children with nephrotic syndrome is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6102.html" rel="external">
          "Complications of nephrotic syndrome in children", section on 'Thromboembolism'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Inflammatory bowel disease (IBD)
         </strong>
         – Patients with IBD have an approximately two- to threefold higher risk of VTE compared with individuals without IBD, and the risk increases substantially during disease flares [
         <a href="#rid42">
          42,43
         </a>
         ]. This is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5865.html" rel="external">
          "Clinical manifestations and complications of inflammatory bowel disease in children and adolescents", section on 'Venous thromboembolism'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Systemic lupus erythematosus and antiphospholipid syndrome
         </strong>
         – The risk of thrombosis in children with systemic lupus erythematosus and antiphospholipid syndrome is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6420.html" rel="external">
          "Childhood-onset systemic lupus erythematosus (SLE): Clinical manifestations and diagnosis", section on 'Thromboembolic'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4667.html" rel="external">
          "Clinical manifestations of antiphospholipid syndrome"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Vascular abnormalities
         </strong>
         – Certain vascular malformations and anatomic abnormalities carry an increased risk of thrombosis (eg, May-Thurner syndrome, Paget-Schroetter syndrome/thoracic outlet syndrome, inferior vena cava atresia). (See
         <a class="medical medical_review" href="/z/d/html/110055.html" rel="external">
          "May-Thurner syndrome"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8211.html" rel="external">
          "Primary (spontaneous) upper extremity deep vein thrombosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other risk factors in hospitalized patients
         </strong>
         – Additional risk factors may be considered when determining the need for thromboprophylaxis in hospitalized patients (eg, prolonged immobility, critical illness, duration of mechanical ventilation). This is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5916.html" rel="external">
          "Venous thrombosis and thromboembolism (VTE) in children: Treatment, prevention, and outcome", section on 'Primary prophylaxis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         These risk factors are characterized by either a protein-losing state, inflammatory state, or vascular disruption, which are consistent with Virchow's triad describing VTE risk. (See
         <a class="medical medical_review" href="/z/d/html/1361.html" rel="external">
          "Overview of the causes of venous thrombosis", section on 'Virchow triad'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinical manifestations of VTE in children vary, depending on the location of the thrombus and degree of vessel occlusion.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Central venous line
         </span>
         <span class="headingEndMark">
          —
         </span>
         Central venous catheter (CVC)-related VTE can present with any of the following [
         <a href="#rid44">
          44-50
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Asymptomatic (most cases)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Repeated loss of CVC patency
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         CVC-related sepsis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Swelling and discoloration of the related limb
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Facial swelling and other signs of superior vena cava syndrome
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prominent collateral circulation in the skin over the chest, back, neck, and face
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pulmonary embolism (PE)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Stroke (in children with right-to-left cardiac shunting)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chylothorax
        </p>
        <p>
        </p>
        <p>
         In a systematic review of 16 cohort studies, which included 1279 children with CVCs, approximately 20 percent of patients had at least one documented VTE, most of which (75 percent) were asymptomatic [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Deep vein thrombosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinical manifestations of deep vein thrombosis (DVT) vary depending on the location. Non-CVC-related DVT can occur in any venous system but most commonly present in the lower extremities, especially in the iliac, femoral, and/or popliteal veins.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lower extremity DVT
         </strong>
         – Lower extremity DVT manifests with unilateral leg, buttock, inguinal, and/or abdominal pain associated with swelling and/or reddish or purple discoloration of the legs. Larger calf diameter in the affected leg compared with the contralateral leg may also be noted. Homans' sign (calf pain on passive dorsiflexion of the foot) is unreliable for signaling the presence of DVT in children [
         <a href="#rid51">
          51
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Upper extremity DVT
         </strong>
         – Outside of the setting of CVC-related VTE, upper extremity DVT is rare in children. Upper extremity DVT manifests with unilateral swelling and discoloration of the arm and hand [
         <a href="#rid51">
          51
         </a>
         ]. Swelling of the face may be noted if the thrombus extends into the superior vena cava. Patients may complain of pain in the affected arm and/or discomfort in the neck, shoulder, or axilla. Effort-related upper extremity DVT (Paget-Schroetter syndrome) is a rare condition that typically affects young, healthy individuals, most commonly males [
         <a href="#rid52">
          52
         </a>
         ]. It is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/8211.html" rel="external">
          "Primary (spontaneous) upper extremity deep vein thrombosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Pulmonary embolism
         </span>
         <span class="headingEndMark">
          —
         </span>
         PE is rare in children but should be considered in the differential diagnosis of cardiorespiratory deterioration in critically ill children [
         <a href="#rid53">
          53-55
         </a>
         ]. PE can manifest with pleuritic chest pain, tachypnea, cough, tachycardia, acute dyspnea, hypoxia, and sudden collapse. Clinical signs of DVT may also be present. Most commonly, however, the clinical manifestations of PE in children, especially young children, are nonspecific and often mimic the clinical symptoms of the underlying disease. (See
         <a class="medical medical_review" href="/z/d/html/16315.html" rel="external">
          "Causes of acute respiratory distress in children"
         </a>
         .)
        </p>
        <p>
         Though PE is rare in children, its reported incidence has increased since the early 2000s [
         <a href="#rid7">
          7
         </a>
         ]. It is uncertain whether the increase represents a true increase in the frequency of PE or an increase in the detection of PE. (See
         <a class="local">
          'Incidence'
         </a>
         above.)
        </p>
        <p>
         Commonly reported risk factors for PE in children include presence of a CVC, trauma, immobility, recent surgery, use of estrogen-containing contraceptives, inflammatory conditions, malignancy, heart disease, dehydration, and obesity [
         <a href="#rid7">
          7,56-60
         </a>
         ].
        </p>
        <p>
         Most PEs in children are nonmassive (ie, without any hemodynamic effects). In one study of 170 children with PE, 71 percent were nonmassive and 29 percent were massive or submassive [
         <a href="#rid61">
          61
         </a>
         ]. Compared with patients with nonmassive PE, those with massive or submassive PE were somewhat younger (median age 12.5 versus 14.4 years) and more likely to have a CVC (59 versus 40 percent) or underlying cardiac condition (33 versus 14 percent). There were 11 PE-related deaths in this cohort (6 percent), all of which occurred in patients with massive or submassive PE.
        </p>
        <p class="headingAnchor" id="H2748144043">
         <span class="h2">
          Other venous thrombosis
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Renal vein thrombosis (RVT)
         </strong>
         - In children, RVT most commonly occurs secondary to nephrotic syndrome and renal transplantation [
         <a href="#rid62">
          62-64
         </a>
         ]. The author of this topic review has also seen RVT as the presenting manifestation of systemic lupus erythematosus; however, this is uncommon [
         <a href="#rid65">
          65
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6102.html" rel="external">
          "Complications of nephrotic syndrome in children", section on 'Thromboembolism'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6143.html" rel="external">
          "Kidney transplantation in children: Complications", section on 'Vascular thrombosis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4668.html" rel="external">
          "Clinical manifestations and diagnosis of systemic lupus erythematosus in adults", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         RVT most often has an insidious onset and produces no symptoms referable to the kidney. In this case, the RVT may first come to attention when the patient presents with a complication resulting from extension or embolism (eg, PE or symptomatic lower extremity DVT if the thrombus extends into the inferior vena cava). When findings referable to the kidney are present, they may include hematuria, proteinuria, anuria, and vomiting. (See
         <a class="medical medical_review" href="/z/d/html/119627.html" rel="external">
          "Renal vein thrombosis in adults", section on 'Clinical features'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In neonates, RVT is the most prevalent non-catheter-related VTE, accounting for approximately 10 percent of all thromboembolic events in newborns [
         <a href="#rid66">
          66
         </a>
         ]. RVT in neonates is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5912.html" rel="external">
          "Neonatal thrombosis: Clinical features and diagnosis", section on 'Renal vein thrombosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Portal vein thrombosis (PVT)
         </strong>
         - Children may develop PVT secondary to liver transplantation, infections, splenectomy, sickle cell disease, chemotherapy, or antiphospholipid syndrome [
         <a href="#rid67">
          67-72
         </a>
         ]. PVT may manifest acutely with symptoms of an acute abdomen, particularly in adolescents [
         <a href="#rid73">
          73
         </a>
         ], or may be asymptomatic for long periods of time until symptoms reflecting chronic portal hypertension occur (eg, splenomegaly or gastrointestinal bleeding secondary to esophageal varices) [
         <a href="#rid74">
          74
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/88014.html" rel="external">
          "Chronic portal vein thrombosis in adults: Clinical manifestations, diagnosis, and management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In neonates, PVT is most often related to umbilical catheterization and sepsis [
         <a href="#rid75">
          75
         </a>
         ]. Neonatal PVT is discussed in a separate topic review. (See
         <a class="medical medical_review" href="/z/d/html/5912.html" rel="external">
          "Neonatal thrombosis: Clinical features and diagnosis", section on 'Portal vein thrombosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cerebral venous thrombosis
         </strong>
         – Cerebral venous thrombosis is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1103.html" rel="external">
          "Cerebral venous thrombosis: Etiology, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3848350685">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ultrasonography is the preferred initial diagnostic study in most children with suspected venous thrombosis. Noncompressibility of the vein with or without visible intraluminal thrombus confirms the diagnosis. Alternative imaging modalities are available (eg, contrast venography, contrast magnetic resonance venography [MRV], computed tomography [CT] venography); however, they are rarely necessary. The exception is suspected pulmonary embolism (PE), for which CT pulmonary angiography (CTPA) is the imaging modality of choice.
        </p>
        <p>
         Duplex ultrasonography is the preferred initial test because it is noninvasive, readily available, does not require sedation, and does not expose the child to ionizing radiation. Though data are limited in children, studies in adults indicate that compression ultrasonography has an acceptable sensitivity and specificity for the diagnosis of venous thrombosis. (See
         <a class="medical medical_review" href="/z/d/html/1351.html" rel="external">
          "Clinical presentation and diagnosis of the nonpregnant adult with suspected deep vein thrombosis of the lower extremity", section on 'Diagnostic ultrasonography suspected first DVT'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8195.html" rel="external">
          "Catheter-related upper extremity venous thrombosis in adults", section on 'Duplex ultrasonography'
         </a>
         .)
        </p>
        <p>
         The diagnostic approach varies somewhat depending on the location of the suspected thrombus [
         <a href="#rid76">
          76
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Catheter-associated thrombosis
         </strong>
         – Patients with signs or symptoms of large vessel thrombosis (eg, swelling and/or discoloration of the related limb) should be evaluated with duplex ultrasound. For mechanical catheter problems, instillation of intravenous contrast into the lumen of the catheter under fluoroscopy may readily demonstrate the presence of thrombus at the tip of the catheter. (See
         <a class="medical medical_review" href="/z/d/html/8195.html" rel="external">
          "Catheter-related upper extremity venous thrombosis in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lower extremity
         </strong>
         – Compression ultrasonography is recommended for initial evaluation of deep vein thrombosis (DVT) in the lower extremities. If ultrasonography is normal and the clinical suspicion of DVT remains high, the study can be repeated after a week [
         <a href="#rid76">
          76
         </a>
         ]. In children with suspected proximal extension of femoral DVT, MRV is the appropriate diagnostic study. CT is a reasonable choice if MRV is not available; however, CT has the disadvantage of exposing the child to radiation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Upper extremity
         </strong>
         – The initial assessment of the peripheral upper extremity, axillary, subclavian, and internal jugular veins should be performed with ultrasonography; however, this modality may be relatively insensitive for detection of central intrathoracic VTE. Ultrasonography can yield false-negative results due to the position of the clavicles (which hinder the view of the distal subclavian veins) and the thoracic cage (which hinders compression of veins in a central location) [
         <a href="#rid77">
          77
         </a>
         ]. Assessment of the central veins for VTE can be performed using MRV, CT, or contrast venography; we prefer MRV because it does not expose the child to radiation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In patients with non-catheter-related upper extremity DVT, a diagnosis of thoracic outlet syndrome (also referred to as Paget-Schroetter syndrome or "effort" thrombosis) should be considered. Establishing this diagnosis may require specialized imaging techniques, as discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/8211.html" rel="external">
          "Primary (spontaneous) upper extremity deep vein thrombosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          PE
         </strong>
         – CTPA is the imaging modality of choice for diagnosis of PE in children [
         <a href="#rid78">
          78,79
         </a>
         ]. Clinical tools commonly used in adult patients to assess the pretest probability of PE (eg, Wells score and D-dimer measurements) do
         <strong>
          not
         </strong>
         appear to perform well in children [
         <a href="#rid56">
          56,57
         </a>
         ]. In a retrospective cohort study, D-dimer and Wells score were not useful in discriminating between children with versus without radiographically confirmed PE [
         <a href="#rid57">
          57
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Other imaging studies that are sometimes used in the evaluation for PE include ventilation perfusion scans and magnetic resonance pulmonary angiography. Use of these modalities is generally limited to instances in which CTPA is contraindicated, not available, or inconclusive. These modalities have the advantage of avoiding ionizing radiation; however, they are more time-consuming and young children generally require sedation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Echocardiography can be useful to provide support for the diagnosis of PE and to provide prognostic information (eg, it may demonstrate right ventricular strain, which is an indicator of poor prognosis). However, it is insensitive and nonspecific for diagnosing PE since many patients with PE have normal echocardiography and because right ventricular strain can be seen in many other conditions. (See
         <a class="medical medical_review" href="/z/d/html/83974.html" rel="external">
          "Echocardiographic assessment of the right heart"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The diagnosis of PE in adult patients is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/8261.html" rel="external">
          "Clinical presentation, evaluation, and diagnosis of the nonpregnant adult with suspected acute pulmonary embolism"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3673809991">
         <span class="h1">
          THROMBOPHILIA TESTING
         </span>
         <span class="headingEndMark">
          —
         </span>
         Once the diagnosis of VTE has been made, it may be appropriate to test for underlying inherited or acquired thrombophilias. The utility of thrombophilia testing depends on the clinical circumstance. Thrombophilia testing is generally
         <strong>
          not
         </strong>
         warranted in patients presenting with a first episode of VTE associated with a central venous catheter (CVC). Our approach to thrombophilia testing is summarized in the algorithm  (
         <a class="graphic graphic_algorithm graphicRef91835" href="/z/d/graphic/91835.html" rel="external">
          algorithm 1
         </a>
         ) and discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5920.html" rel="external">
          "Thrombophilia testing in children and adolescents"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1260953679">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of VTE depends on the location of the thrombus:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Deep vein thrombosis (DVT)
         </strong>
         – Mimics of upper or lower extremity DVT include other conditions that present with swelling, erythema/discoloration, and tenderness of the extremity:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Baker's cyst (see
         <a class="medical medical_review" href="/z/d/html/14924.html" rel="external">
          "Popliteal (Baker's) cyst"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cellulitis (see
         <a class="medical medical_review" href="/z/d/html/110529.html" rel="external">
          "Cellulitis and skin abscess: Epidemiology, microbiology, clinical manifestations, and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Musculoskeletal injury (see
         <a class="medical medical_review" href="/z/d/html/90232.html" rel="external">
          "Calf injuries not involving the Achilles tendon"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6514.html" rel="external">
          "Approach to acute knee pain and injury in children and skeletally immature adolescents"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Lymphangitis or lymph obstruction (see
         <a class="medical medical_review" href="/z/d/html/2741.html" rel="external">
          "Lymphangitis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Superficial thrombophlebitis (see
         <a class="medical medical_review" href="/z/d/html/8199.html" rel="external">
          "Superficial vein thrombosis and phlebitis of the lower extremity veins"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The history and physical examination findings can often distinguish DVT from these conditions, though ultrasonography is ultimately required to make the diagnosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pulmonary embolus (PE)
         </strong>
         – The differential diagnosis of PE in children includes other entities that present with chest pain  (
         <a class="graphic graphic_table graphicRef96739" href="/z/d/graphic/96739.html" rel="external">
          table 3
         </a>
         ), dyspnea, and hypoxia. The approach to children with these complaints is reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/96737.html" rel="external">
          "Causes of nontraumatic chest pain in children and adolescents"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16315.html" rel="external">
          "Causes of acute respiratory distress in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6437.html" rel="external">
          "Approach to cyanosis in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H575327478">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/117261.html" rel="external">
          "Society guideline links: Thrombotic diseases in infants and children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H15808452">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology
         </strong>
         – Venous thrombosis and thromboembolism (VTE; including venous thrombosis and pulmonary embolism [PE]) are relatively uncommon in children, with an estimated annual incidence of approximately 0.2 per 10,000 children. Rates of VTE are highest among children with underlying medical conditions, such as malignancy and cardiac disease. The risk of VTE is substantially lower in children compared with adults because several protective factors are present during childhood. (See
         <a class="local">
          'Incidence'
         </a>
         above and
         <a class="local">
          'Risk of VTE in children versus adults'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk factors for VTE
         </strong>
         – Important risk factors for VTE in pediatric patients include  (
         <a class="graphic graphic_table graphicRef122844" href="/z/d/graphic/122844.html" rel="external">
          table 1
         </a>
         ) (see
         <a class="local">
          'Risk factors'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Central venous catheters (CVCs)
         </strong>
         – In children, approximately one- to two-thirds of VTEs are associated with the use of CVCs. Indwelling CVCs are thrombogenic because they present a foreign intravascular surface, damage vessel walls, and disrupt blood flow. (See
         <a class="local">
          'Central venous access devices'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Inherited thrombophilia (IT)
         </strong>
         – The association between IT and VTE in children is less well established than in adults. In children with VTE, the reported prevalence of IT ranges from 10 to 60 percent. The most common IT disorders include factor V Leiden; prothrombin G20210A mutation; and deficiencies of antithrombin, protein C, and protein S. The approach to testing for IT in children who have had a VTE episode is summarized in the algorithm  (
         <a class="graphic graphic_algorithm graphicRef91835" href="/z/d/graphic/91835.html" rel="external">
          algorithm 1
         </a>
         ) and discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5920.html" rel="external">
          "Thrombophilia testing in children and adolescents", section on 'Children with venous thromboembolism'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Other conditions
         </strong>
         – Other conditions that are associated with increased VTE risk in children include infection, malignancy, congenital heart disease, trauma, surgery (particularly cardiac and orthopedic surgery), obesity, estrogen-containing contraceptives, protein-losing conditions (eg, nephrotic syndrome, inflammatory bowel disease [IBD]), and autoimmune conditions (eg, systemic lupus erythematosus). (See
         <a class="local">
          'Other risk factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         – Clinical manifestations of VTE in children depend on the location of the thrombus and degree of vessel occlusion (see
         <a class="local">
          'Clinical manifestations'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          CVC-related VTE
         </strong>
         – CVC-related VTEs are usually asymptomatic. When symptoms are present, they may include (see
         <a class="local">
          'Central venous line'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Repeated loss of CVC patency
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         CVC-related sepsis, swelling, and discoloration of the related limb
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Facial swelling and other symptoms of superior vena cava syndrome
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Prominent collateral circulation in the skin over the chest, back, neck, and face
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         PE
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Stroke (in patients with right-to-left cardiac shunt)
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Chylothorax
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Deep vein thrombosis (DVT)
         </strong>
         – Non-CVC-related DVTs can occur in any venous system but most commonly present in the lower extremities, especially in the iliac, femoral, and/or popliteal veins. VTE in the lower extremities manifests with leg, buttock, inguinal, and/or abdominal pain associated with swelling and reddish or purple discoloration of the legs. (See
         <a class="local">
          'Deep vein thrombosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Pulmonary embolism (PE)
         </strong>
         – The clinical manifestations of PE can manifest with pleuritic chest pain, tachypnea, cough, tachycardia, acute dyspnea, hypoxia, and sudden collapse. A high index of clinical suspicion is warranted in children with risk factors for PE, including obesity, contraceptive use, trauma, CVC, and immobility. (See
         <a class="local">
          'Pulmonary embolism'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – Ultrasonography is the preferred initial diagnostic study in most children with suspected venous thrombosis. Noncompressibility of the vein with or without visible intraluminal thrombus confirms the diagnosis. Alternative imaging modalities are available (eg, contrast venography, contrast magnetic resonance venography [MRV], computed tomography [CT] venography); however, they are rarely necessary. CT pulmonary angiography (CTPA) is the imaging modality of choice for diagnosis of PE in children. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – The differential diagnosis of VTE depends on the location of the thrombus. Mimics of upper or lower extremity DVT include other conditions that present with swelling, erythema/discoloration, and tenderness of the extremity (eg, Baker's cyst, cellulitis, musculoskeletal injury, lymphangitis, and superficial thrombophlebitis). The differential diagnosis of PE in children includes other entities that present with chest pain  (
         <a class="graphic graphic_table graphicRef96739" href="/z/d/graphic/96739.html" rel="external">
          table 3
         </a>
         ), dyspnea, and hypoxia. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           van Ommen CH, Heijboer H, Büller HR, et al. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr 2001; 139:676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tuckuviene R, Christensen AL, Helgestad J, et al. Pediatric venous and arterial noncerebral thromboembolism in Denmark: a nationwide population-based study. J Pediatr 2011; 159:663.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raffini L, Huang YS, Witmer C, Feudtner C. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics 2009; 124:1001.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Setty BA, O'Brien SH, Kerlin BA. Pediatric venous thromboembolism in the United States: a tertiary care complication of chronic diseases. Pediatr Blood Cancer 2012; 59:258.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Takemoto CM, Sohi S, Desai K, et al. Hospital-associated venous thromboembolism in children: incidence and clinical characteristics. J Pediatr 2014; 164:332.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Brien SH, Stanek JR, Witmer CM, Raffini L. The Continued Rise of Venous Thromboembolism Across US Children's Hospitals. Pediatrics 2022; 149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carpenter SL, Richardson T, Hall M. Increasing rate of pulmonary embolism diagnosed in hospitalized children in the United States from 2001 to 2014. Blood Adv 2018; 2:1403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andrew M, Vegh P, Johnston M, et al. Maturation of the hemostatic system during childhood. Blood 1992; 80:1998.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Massicotte P, Leaker M, Marzinotto V, et al. Enhanced thrombin regulation during warfarin therapy in children compared to adults. Thromb Haemost 1998; 80:570.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitchell L, Piovella F, Ofosu F, Andrew M. Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children. Blood 1991; 78:2299.
          </a>
         </li>
         <li class="breakAll">
          Virchow R. Phlogose und thrombose im gefässsystem. In: Gesammelte Abhandlungen zur Wissenschaftlichen Medizin, Virchow R (Ed), von Meidinger Sohn &amp; Comp, Frankfurt am Main, Germany 1856. p.458.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuhle S, Massicotte P, Chan A, et al. Systemic thromboembolism in children. Data from the 1-800-NO-CLOTS Consultation Service. Thromb Haemost 2004; 92:722.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Menéndez JJ, Verdú C, Calderón B, et al. Incidence and risk factors of superficial and deep vein thrombosis associated with peripherally inserted central catheters in children. J Thromb Haemost 2016; 14:2158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jaffray J, Witmer C, O'Brien SH, et al. Peripherally inserted central catheters lead to a high risk of venous thromboembolism in children. Blood 2020; 135:220.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chopra V, Anand S, Hickner A, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet 2013; 382:311.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel N, Petersen TL, Simpson PM, et al. Rates of Venous Thromboembolism and Central Line-Associated Bloodstream Infections Among Types of Central Venous Access Devices in Critically Ill Children. Crit Care Med 2020; 48:1340.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kanin M, Young G. Incidence of thrombosis in children with tunneled central venous access devices versus peripherally inserted central catheters (PICCs). Thromb Res 2013; 132:527.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dubois J, Rypens F, Garel L, et al. Incidence of deep vein thrombosis related to peripherally inserted central catheters in children and adolescents. CMAJ 2007; 177:1185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Massicotte MP, Dix D, Monagle P, et al. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998; 133:770.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Worly JM, Fortenberry JD, Hansen I, et al. Deep venous thrombosis in children with diabetic ketoacidosis and femoral central venous catheters. Pediatrics 2004; 113:e57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ligia S, Morano SG, Kaiser F, et al. Peripherally inserted central venous catheter for pediatric acute leukemia: A retrospective 11-year single-center experience. J Vasc Access 2023; :11297298231185222.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Middeldorp S, Henkens CM, Koopman MM, et al. The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis. Ann Intern Med 1998; 128:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simioni P, Sanson BJ, Prandoni P, et al. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost 1999; 81:198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kosch A, Koch HG, Heinecke A, et al. Increased fasting total homocysteine plasma levels as a risk factor for thromboembolism in children. Thromb Haemost 2004; 91:308.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chalmers EA. Heritable thrombophilia and childhood thrombosis. Blood Rev 2001; 15:181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tormene D, Simioni P, Prandoni P, et al. The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study. Blood 2002; 100:2403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neshat-Vahid S, Pierce R, Hersey D, et al. Association of thrombophilia and catheter-associated thrombosis in children: a systematic review and meta-analysis. J Thromb Haemost 2016; 14:1749.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nowak-Göttl U, Dübbers A, Kececioglu D, et al. Factor V Leiden, protein C, and lipoprotein (a) in catheter-related thrombosis in childhood: a prospective study. J Pediatr 1997; 131:608.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bonduel M, Hepner M, Sciuccati G, et al. Prothrombotic abnormalities in children with venous thromboembolism. J Pediatr Hematol Oncol 2000; 22:66.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bonduel M, Hepner M, Sciuccati G, et al. Factor V Leiden and prothrombin gene G20210A mutation in children with venous thromboembolism. Thromb Haemost 2002; 87:972.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lawson SE, Butler D, Enayat MS, Williams MD. Congenital thrombophilia and thrombosis: a study in a single centre. Arch Dis Child 1999; 81:176.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Ommen CH, Peters M. Venous thromboembolic disease in childhood. Semin Thromb Hemost 2003; 29:391.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Ommen CH, Heijboer H, van den Dool EJ, et al. Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome. J Thromb Haemost 2003; 1:2516.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Revel-Vilk S, Chan A, Bauman M, Massicotte P. Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease. J Thromb Haemost 2003; 1:915.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Young G, Albisetti M, Bonduel M, et al. Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Circulation 2008; 118:1373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Witmer CM, Takemoto CM. Pediatric Hospital Acquired Venous Thromboembolism. Front Pediatr 2017; 5:198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arlikar SJ, Atchison CM, Amankwah EK, et al. Development of a new risk score for hospital-associated venous thromboembolism in critically-ill children not undergoing cardiothoracic surgery. Thromb Res 2015; 136:717.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Whitworth H, Sartain SE, Kumar R, et al. Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C. Blood 2021; 138:190.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thompson AJ, McSwain SD, Webb SA, et al. Venous thromboembolism prophylaxis in the pediatric trauma population. J Pediatr Surg 2013; 48:1413.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Arendonk KJ, Schneider EB, Haider AH, et al. Venous thromboembolism after trauma: when do children become adults? JAMA Surg 2013; 148:1123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allen CJ, Murray CR, Meizoso JP, et al. Risk factors for venous thromboembolism after pediatric trauma. J Pediatr Surg 2016; 51:168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nguyen GC, Bernstein CN, Bitton A, et al. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. Gastroenterology 2014; 146:835.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuenzig ME, Bitton A, Carroll MW, et al. Inflammatory Bowel Disease Increases the Risk of Venous Thromboembolism in Children: A Population-Based Matched Cohort Study. J Crohns Colitis 2021; 15:2031.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994; 83:1251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000; 47:763.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Journeycake JM, Buchanan GR. Catheter-related deep venous thrombosis and other catheter complications in children with cancer. J Clin Oncol 2006; 24:4575.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marie I, Lévesque H, Cailleux N, et al. [Deep venous thrombosis of the upper limbs. Apropos of 49 cases]. Rev Med Interne 1998; 19:399.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mulvihill SJ, Fonkalsrud EW. Complications of superior versus inferior vena cava occlusion in infants receiving central total parenteral nutrition. J Pediatr Surg 1984; 19:752.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rockoff MA, Gang DL, Vacanti JP. Fatal pulmonary embolism following removal of a central venous catheter. J Pediatr Surg 1984; 19:307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Derish MT, Smith DW, Frankel LR. Venous catheter thrombus formation and pulmonary embolism in children. Pediatr Pulmonol 1995; 20:349.
          </a>
         </li>
         <li class="breakAll">
          Pipe S, Goldenberg N. Acquired disorders of hemostasis. In: Nathan and Oski's Hematology and Oncology of Infancy and Childhood, 8th Ed, Orkin SH, Fisher DE, Ginsburg D, Look AT, Lux SE, Nathan DG (Eds), Saunders, Philadelphia, PA 2015. Vol 1, p.1103.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brandão LR, Williams S, Kahr WH, et al. Exercise-induced deep vein thrombosis of the upper extremity. 1. Literature review. Acta Haematol 2006; 115:214.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Byard RW, Cutz E. Sudden and unexpected death in infancy and childhood due to pulmonary thromboembolism. An autopsy study. Arch Pathol Lab Med 1990; 114:142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matthew DJ, Levin M. Pulmonary thromboembolism in children. Intensive Care Med 1986; 12:404.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agha BS, Sturm JJ, Simon HK, Hirsh DA. Pulmonary embolism in the pediatric emergency department. Pediatrics 2013; 132:663.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Biss TT, Brandão LR, Kahr WH, et al. Clinical features and outcome of pulmonary embolism in children. Br J Haematol 2008; 142:808.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Biss TT, Brandão LR, Kahr WH, et al. Clinical probability score and D-dimer estimation lack utility in the diagnosis of childhood pulmonary embolism. J Thromb Haemost 2009; 7:1633.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hancock HS, Wang M, Gist KM, et al. Cardiac findings and long-term thromboembolic outcomes following pulmonary embolism in children: a combined retrospective-prospective inception cohort study. Cardiol Young 2013; 23:344.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buck JR, Connors RH, Coon WW, et al. Pulmonary embolism in children. J Pediatr Surg 1981; 16:385.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldsby RE, Saulys AJ, Helton JG. Pediatric pulmonary artery thromboembolism: an illustrative case. Pediatr Emerg Care 1996; 12:105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pelland-Marcotte MC, Tucker C, Klaassen A, et al. Outcomes and risk factors of massive and submassive pulmonary embolism in children: a retrospective cohort study. Lancet Haematol 2019; 6:e144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tinaztepe K, Buyan N, Tinaztepe B, Akkök N. The association of nephrotic syndrome and renal vein thrombosis: a clinicopathological analysis of eight pediatric patients. Turk J Pediatr 1989; 31:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chugh KS, Malik N, Uberoi HS, et al. Renal vein thrombosis in nephrotic syndrome--a prospective study and review. Postgrad Med J 1981; 57:566.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harmon WE, Stablein D, Alexander SR, Tejani A. Graft thrombosis in pediatric renal transplant recipients. A report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1991; 51:406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Asherson RA, Lanham JG, Hull RG, et al. Renal vein thrombosis in systemic lupus erythematosus: association with the "lupus anticoagulant". Clin Exp Rheumatol 1984; 2:75.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brandão LR, Simpson EA, Lau KK. Neonatal renal vein thrombosis. Semin Fetal Neonatal Med 2011; 16:323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brady L, Magilavy D, Black DD. Portal vein thrombosis associated with antiphospholipid antibodies in a child. J Pediatr Gastroenterol Nutr 1996; 23:470.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arav-Boger R, Reif S, Bujanover Y. Portal vein thrombosis caused by protein C and protein S deficiency associated with cytomegalovirus infection. J Pediatr 1995; 126:586.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skarsgard E, Doski J, Jaksic T, et al. Thrombosis of the portal venous system after splenectomy for pediatric hematologic disease. J Pediatr Surg 1993; 28:1109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arnold KE, Char G, Serjeant GR. Portal vein thrombosis in a child with homozygous sickle-cell disease. West Indian Med J 1993; 42:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harper PL, Edgar PF, Luddington RJ, et al. Protein C deficiency and portal thrombosis in liver transplantation in children. Lancet 1988; 2:924.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brisse H, Orbach D, Lassau N, et al. Portal vein thrombosis during antineoplastic chemotherapy in children: report of five cases and review of the literature. Eur J Cancer 2004; 40:2659.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stringer MD, Marshall MM, Muiesan P, et al. Survival and outcome after hepatic artery thrombosis complicating pediatric liver transplantation. J Pediatr Surg 2001; 36:888.
          </a>
         </li>
         <li class="breakAll">
          Andrew M, Mongale PT, Brooker L. Thromboembolic complications during infancy and childhood, BC Decker Inc, Hamilton, Ontario 2000.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams S, Chan AK. Neonatal portal vein thrombosis: diagnosis and management. Semin Fetal Neonatal Med 2011; 16:329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chalmers E, Ganesen V, Liesner R, et al. Guideline on the investigation, management and prevention of venous thrombosis in children. Br J Haematol 2011; 154:196.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Male C, Chait P, Ginsberg JS, et al. Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with Asparaginase. Thromb Haemost 2002; 87:593.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tang CX, Schoepf UJ, Chowdhury SM, et al. Multidetector computed tomography pulmonary angiography in childhood acute pulmonary embolism. Pediatr Radiol 2015; 45:1431.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Degerstedt SG, Winant AJ, Lee EY. Pediatric Pulmonary Embolism: Imaging Guidelines and Recommendations. Radiol Clin North Am 2022; 60:69.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5918 Version 35.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11713446" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21596390" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Pediatric venous and arterial noncerebral thromboembolism in Denmark: a nationwide population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19736261" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22038730" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Pediatric venous thromboembolism in the United States: a tertiary care complication of chronic diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24332452" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Hospital-associated venous thromboembolism in children: incidence and clinical characteristics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35156127" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : The Continued Rise of Venous Thromboembolism Across US Children's Hospitals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29907635" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Increasing rate of pulmonary embolism diagnosed in hospitalized children in the United States from 2001 to 2014.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1391957" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Maturation of the hemostatic system during childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9798971" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Enhanced thrombin regulation during warfarin therapy in children compared to adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1718494" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1718494" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15467901" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Systemic thromboembolism in children. Data from the 1-800-NO-CLOTS Consultation Service.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27558946" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Incidence and risk factors of superficial and deep vein thrombosis associated with peripherally inserted central catheters in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31909784" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Peripherally inserted central catheters lead to a high risk of venous thromboembolism in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23697825" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32590391" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Rates of Venous Thromboembolism and Central Line-Associated Bloodstream Infections Among Types of Central Venous Access Devices in Critically Ill Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24055175" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Incidence of thrombosis in children with tunneled central venous access devices versus peripherally inserted central catheters (PICCs).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17978273" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Incidence of deep vein thrombosis related to peripherally inserted central catheters in children and adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9842042" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14702496" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Deep venous thrombosis in children with diabetic ketoacidosis and femoral central venous catheters.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37408515" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Peripherally inserted central venous catheter for pediatric acute leukemia: A retrospective 11-year single-center experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9424976" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10063991" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Incidence of venous thromboembolism in families with inherited thrombophilia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14961159" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Increased fasting total homocysteine plasma levels as a risk factor for thromboembolism in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11792119" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Heritable thrombophilia and childhood thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12239149" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27306795" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Association of thrombophilia and catheter-associated thrombosis in children: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9386668" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Factor V Leiden, protein C, and lipoprotein (a) in catheter-related thrombosis in childhood: a prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10695825" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Prothrombotic abnormalities in children with venous thromboembolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12083504" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Factor V Leiden and prothrombin gene G20210A mutation in children with venous thromboembolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10490533" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Congenital thrombophilia and thrombosis: a study in a single centre.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14517751" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Venous thromboembolic disease in childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14675086" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12871356" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18779442" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28975127" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Pediatric Hospital Acquired Venous Thromboembolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25979250" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Development of a new risk score for hospital-associated venous thromboembolism in critically-ill children not undergoing cardiothoracic surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33895804" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23845640" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Venous thromboembolism prophylaxis in the pediatric trauma population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24173244" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Venous thromboembolism after trauma: when do children become adults?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26547285" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Risk factors for venous thromboembolism after pediatric trauma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24462530" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34175936" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Inflammatory Bowel Disease Increases the Risk of Venous Thromboembolism in Children: A Population-Based Matched Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8118029" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10832734" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17008698" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Catheter-related deep venous thrombosis and other catheter complications in children with cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9775181" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : [Deep venous thrombosis of the upper limbs. Apropos of 49 cases].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6440968" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Complications of superior versus inferior vena cava occlusion in infants receiving central total parenteral nutrition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6747797" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Fatal pulmonary embolism following removal of a central venous catheter.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8649913" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Venous catheter thrombus formation and pulmonary embolism in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8649913" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Venous catheter thrombus formation and pulmonary embolism in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16549899" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Exercise-induced deep vein thrombosis of the upper extremity. 1. Literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2302030" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Sudden and unexpected death in infancy and childhood due to pulmonary thromboembolism. An autopsy study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3794057" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Pulmonary thromboembolism in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23999960" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Pulmonary embolism in the pediatric emergency department.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18564359" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Clinical features and outcome of pulmonary embolism in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19682234" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Clinical probability score and D-dimer estimation lack utility in the diagnosis of childhood pulmonary embolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23088931" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Cardiac findings and long-term thromboembolic outcomes following pulmonary embolism in children: a combined retrospective-prospective inception cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7252746" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Pulmonary embolism in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8859919" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Pediatric pulmonary artery thromboembolism: an illustrative case.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30772417" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Outcomes and risk factors of massive and submassive pulmonary embolism in children: a retrospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2609431" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : The association of nephrotic syndrome and renal vein thrombosis: a clinicopathological analysis of eight pediatric patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7329894" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Renal vein thrombosis in nephrotic syndrome--a prospective study and review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1994535" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Graft thrombosis in pediatric renal transplant recipients. A report of the North American Pediatric Renal Transplant Cooperative Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6442640" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Renal vein thrombosis in systemic lupus erythematosus: association with the "lupus anticoagulant".
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21865100" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Neonatal renal vein thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8956190" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Portal vein thrombosis associated with antiphospholipid antibodies in a child.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7699538" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Portal vein thrombosis caused by protein C and protein S deficiency associated with cytomegalovirus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8308671" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Thrombosis of the portal venous system after splenectomy for pediatric hematologic disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8503211" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Portal vein thrombosis in a child with homozygous sickle-cell disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2902380" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Protein C deficiency and portal thrombosis in liver transplantation in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15571949" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Portal vein thrombosis during antineoplastic chemotherapy in children: report of five cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11381419" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Survival and outcome after hepatic artery thrombosis complicating pediatric liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11381419" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Survival and outcome after hepatic artery thrombosis complicating pediatric liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21925985" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Neonatal portal vein thrombosis: diagnosis and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21595646" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Guideline on the investigation, management and prevention of venous thrombosis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12008940" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with Asparaginase.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25846076" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Multidetector computed tomography pulmonary angiography in childhood acute pulmonary embolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34836567" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Pediatric Pulmonary Embolism: Imaging Guidelines and Recommendations.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
